AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20575089 — intervention group
Group type: EXPERIMENTAL
Intervention: Segregated clinic (PA-free)
Number of subjects: 39
Study 20575089 — intervention group
Group type: COMPARATOR
Intervention: Mixed clinic (PA-positive)
Number of subjects: 39
Study 20575089 — intervention group
Group type: EXPERIMENTAL
Intervention: New clinic with proper hygiene precautions
Number of subjects: 39
Study 20575089 — intervention group
Group type: COMPARATOR
Intervention: Old site (mixed clinic)
Number of subjects: 39
Study 17610321 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week group-education program for RA
Number of subjects: 208
Study 17610321 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 208
Study 16116005 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (2.2 mL of 0.5% hyperbaric bupivacaine plus 0.2 mg morphine)
Number of subjects: 100
Study 16116005 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia (2% lidocaine with epinephrine 1:400,000, 18‐23 mL, followed by 3 mg of morphine after delivery)
Number of subjects: 100
Study 16116005 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal outcomes (assessed by Apgar scores and umbilical arterial blood gas analysis)
Number of subjects: 100
Study 11823107 — intervention group
Group type: EXPERIMENTAL
Intervention: Localization-related epilepsy (LRE) with interictal psychosis
Number of subjects: 653
Study 11823107 — intervention group
Group type: COMPARATOR
Intervention: Localization-related epilepsy (LRE)
Number of subjects: 653
Study 10027033 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-ketamine 1 mg/kg (PRE group)
Number of subjects: 60
Study 10027033 — intervention group
Group type: COMPARATOR
Intervention: Saline (PLA group)
Number of subjects: 60
Study 10027033 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline followed by (R)-ketamine 1 mg/kg (POST group)
Number of subjects: 60
Study 10027033 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine consumption (all groups)
Number of subjects: 60
Study 10027033 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesic consumption at 24 h and 7 days (all groups)
Number of subjects: 60
Study 1492006 — intervention group
Group type: EXPERIMENTAL
Intervention: ciprofloxacin 500 mg twice/day for 10 days
Number of subjects: 16
Study 1492006 — intervention group
Group type: COMPARATOR
Intervention: placebo twice/day for 10 days
Number of subjects: 16
Study 3714290 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm ergometer training programme (30 min per day, 5 days per week, for 8 consecutive weeks at 80% of peak heart rate, 50 rev/min)
Number of subjects: 10
Study 3714290 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm ergometer training programme
Number of subjects: 10
Study 3714290 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 10
Study 28968870 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg once daily for 4 weeks
Number of subjects: 120
Study 28968870 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg once daily for 4 weeks
Number of subjects: 120
Study 28968870 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both drugs
Number of subjects: 120
Study 27188698 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 20000
Study 27188698 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20000
Study 25470442 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term temporal framing for at-risk nonsmokers
Number of subjects: 395
Study 25470442 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term temporal framing for at-risk nonsmokers
Number of subjects: 395
Study 25470442 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term temporal framing for smokers
Number of subjects: 395
Study 25470442 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-CFC smokers
Number of subjects: 395
Study 23397303 — intervention group
Group type: EXPERIMENTAL
Intervention: Actigraph GT3X
Number of subjects: 80
Study 23397303 — intervention group
Group type: EXPERIMENTAL
Intervention: DynaPort MoveMonitor
Number of subjects: 80
Study 21244215 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% DHEA
Number of subjects: 114
Study 21244215 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% DHEA
Number of subjects: 114
Study 21244215 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% DHEA
Number of subjects: 114
Study 21244215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 18451734 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimbrolide-coated lenses
Number of subjects: 10
Study 18451734 — intervention group
Group type: COMPARATOR
Intervention: Uncoated contact lenses
Number of subjects: 10
Study 16737407 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological interventions
Number of subjects: 81
Study 16737407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacological interventions
Number of subjects: 81
Study 16737407 — intervention group
Group type: EXPERIMENTAL
Intervention: All studies combined
Number of subjects: 81
Study 15248440 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine (600 mg in the morning and evening before examination) with intravenous saline hydration
Number of subjects: 120
Study 15248440 — intervention group
Group type: COMPARATOR
Intervention: Control group (hydration alone)
Number of subjects: 120
Study 10856864 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-right anterolateral thoracotomy (test group)
Number of subjects: 100
Study 10856864 — intervention group
Group type: COMPARATOR
Intervention: Median sternotomy (control group)
Number of subjects: 100
Study 9663358 — intervention group
Group type: EXPERIMENTAL
Intervention: Hylan G-F 20 (2 mL, three intra-articular injections, 1 week apart)
Number of subjects: 117
Study 9663358 — intervention group
Group type: COMPARATOR
Intervention: Physiologic buffered saline solution (2 mL, three injections at the same intervals)
Number of subjects: 117
Study 9663358 — intervention group
Group type: EXPERIMENTAL
Intervention: Hylan G-F 20
Number of subjects: 117
Study 9663358 — intervention group
Group type: COMPARATOR
Intervention: Physiologic buffered saline solution
Number of subjects: 117
Study 7930740 — intervention group
Group type: COMPARATOR
Intervention: Mitogen stimulation
Number of subjects: 0
Study 7930740 — intervention group
Group type: COMPARATOR
Intervention: Egg antigens stimulation
Number of subjects: 0
Study 7930740 — intervention group
Group type: COMPARATOR
Intervention: Adult worm antigen stimulation
Number of subjects: 0
Study 2856597 — intervention group
Group type: EXPERIMENTAL
Intervention: cimetidine 300 mg QID
Number of subjects: 338
Study 2856597 — intervention group
Group type: EXPERIMENTAL
Intervention: cimetidine 800 mg HS
Number of subjects: 338
Study 2856597 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 300 mg HS
Number of subjects: 338
Study 30030456 — intervention group
Group type: EXPERIMENTAL
Intervention: narrative-AVG
Number of subjects: 4
Study 30030456 — intervention group
Group type: EXPERIMENTAL
Intervention: AVG
Number of subjects: 4
Study 30030456 — intervention group
Group type: EXPERIMENTAL
Intervention: narrative-SVG
Number of subjects: 4
Study 30030456 — intervention group
Group type: COMPARATOR
Intervention: SVG
Number of subjects: 4
Study 28109467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (60mg total over three days)
Number of subjects: 93
Study 28109467 — intervention group
Group type: COMPARATOR
Intervention: Control (no dexamethasone)
Number of subjects: 93
Study 25705653 — intervention group
Group type: EXPERIMENTAL
Intervention: DBM injection (n = 14)
Number of subjects: 29
Study 25705653 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without injection (n = 15)
Number of subjects: 29
Study 23159586 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief smoking cessation intervention
Number of subjects: 179
Study 23159586 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief smoking cessation intervention plus nicotine replacement therapy
Number of subjects: 179
Study 23159586 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 179
Study 21176029 — intervention group
Group type: EXPERIMENTAL
Intervention: Uridine (2 g)
Number of subjects: 17
Study 21176029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 18408090 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (Botox, 2x50 units)
Number of subjects: 22
Study 18408090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 16678893 — intervention group
Group type: EXPERIMENTAL
Intervention: Population program aimed at reducing dietary salt (half the intake of salt)
Number of subjects: 924
Study 16678893 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of effectiveness format (NNT, RRR, avoided cases of heart attack, increase in longevity)
Number of subjects: 924
Study 16678893 — intervention group
Group type: EXPERIMENTAL
Intervention: Population program
Number of subjects: 924
Study 12800416 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin combined with 20 ml of Shengmai Injection (SMI)
Number of subjects: 40
Study 12800416 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin combined with 40 ml of Shengmai Injection (SMI)
Number of subjects: 40
Study 12800416 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin combined with 60 ml of Shengmai Injection (SMI)
Number of subjects: 40
Study 12800416 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Shengmai Injection)
Number of subjects: 40
Study 10693631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytomegalovirus immune globulin (CMVIG) prophylaxis after OLT
Number of subjects: 0
Study 9002785 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Plaque Remover‐D7
Number of subjects: 24
Study 9002785 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Ultra Plaque Remover‐D9
Number of subjects: 24
Study 9002785 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 24
Study 1580290 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibition (Perindopril)
Number of subjects: 480
Study 4077545 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Management Training Program (SCRPA) for school-age children (ages 6-14), consisting of eight 90-minute classes for both child and parent(s) scheduled twice a week for 4 weeks.
Number of subjects: 59
Study 4077545 — intervention group
Group type: COMPARATOR
Intervention: Self-Management Training Program (SCRPA) for preschool children (ages 2-5), consisting of six 1-hour classes scheduled twice a week for 3 weeks.
Number of subjects: 59
Study 4077545 — intervention group
Group type: COMPARATOR
Intervention: Control group for school-age children (ages 6-14).
Number of subjects: 59
Study 4077545 — intervention group
Group type: COMPARATOR
Intervention: Control group for preschool children (ages 2-5).
Number of subjects: 59
Study 31408467 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel drink powder (4 g betaine, 800 μg folic acid, 5.2 μg vitamin B12, and 2.8 mg vitamin B2)
Number of subjects: 298
Study 31408467 — intervention group
Group type: EXPERIMENTAL
Intervention: UNIMMAP (widely used multiple micronutrient tablet containing 15 micronutrients)
Number of subjects: 298
Study 31408467 — intervention group
Group type: COMPARATOR
Intervention: Novel drink powder
Number of subjects: 298
Study 31408467 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 298
Study 28399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein Concentrate (WPC)
Number of subjects: 41
Study 28399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef Protein
Number of subjects: 41
Study 28399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed Chicken Protein (Chx)
Number of subjects: 41
Study 28399016 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (Control)
Number of subjects: 41
Study 26727095 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve preserving distal gastrectomy (VPG)
Number of subjects: 163
Study 26727095 — intervention group
Group type: COMPARATOR
Intervention: Conventional distal gastrectomy (CG)
Number of subjects: 163
Study 24322331 — intervention group
Group type: EXPERIMENTAL
Intervention: DZ1 (10-23 DNAzyme)
Number of subjects: 40
Study 24322331 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40
Study 22873117 — intervention group
Group type: EXPERIMENTAL
Intervention: l-NAME (NO synthase inhibitor)
Number of subjects: 14
Study 22873117 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution (control site)
Number of subjects: 14
Study 22873117 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (COX pathway inhibitor)
Number of subjects: 14
Study 20845218 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of moderate-intensity cycling at approximately 60% of maximal heart rate
Number of subjects: 10
Study 20845218 — intervention group
Group type: COMPARATOR
Intervention: Rest (no exercise)
Number of subjects: 10
Study 17259476 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g HV‐HPMC
Number of subjects: 31
Study 17259476 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g HV‐HPMC
Number of subjects: 31
Study 17259476 — intervention group
Group type: COMPARATOR
Intervention: Control meal (8 g cellulose)
Number of subjects: 31
Study 15734080 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-sulbactam
Number of subjects: 96
Study 15734080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 12195172 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear peak-clipper
Number of subjects: 360
Study 12195172 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear compression limiter
Number of subjects: 360
Study 12195172 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide dynamic range compressor
Number of subjects: 360
Study 12195172 — intervention group
Group type: EXPERIMENTAL
Intervention: Aided condition
Number of subjects: 360
Study 12195172 — intervention group
Group type: COMPARATOR
Intervention: Unaided condition
Number of subjects: 360
Study 10193824 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodialysis with a biocompatible membrane (polysulfone)
Number of subjects: 53
Study 10193824 — intervention group
Group type: COMPARATOR
Intervention: Haemodialysis with a bioincompatible membrane (cuprophane)
Number of subjects: 53
Study 7762842 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine infusion, 80 micrograms.kg-1.min-1
Number of subjects: 75
Study 7762842 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine infusion
Number of subjects: 75
Study 7762842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 2268865 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow‐K (wax-matrix tablet)
Number of subjects: 18
Study 2268865 — intervention group
Group type: COMPARATOR
Intervention: K‐Dur (microencapsulated tablet)
Number of subjects: 18
Study 2268865 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow‐K
Number of subjects: 18
Study 2268865 — intervention group
Group type: COMPARATOR
Intervention: K‐Dur
Number of subjects: 18
Study 78384 — intervention group
Group type: EXPERIMENTAL
Intervention: E. coli H‐10407 (C.F.A.+) at a dose of 10(8)
Number of subjects: 25
Study 78384 — intervention group
Group type: EXPERIMENTAL
Intervention: E. coli H‐10407 (C.F.A.+)
Number of subjects: 25
Study 78384 — intervention group
Group type: COMPARATOR
Intervention: E. coli H‐10407‐P (C.F.A.‐)
Number of subjects: 25
Study 31368518 — intervention group
Group type: EXPERIMENTAL
Intervention: BF‐200 ALA
Number of subjects: 69
Study 31368518 — intervention group
Group type: COMPARATOR
Intervention: MAL
Number of subjects: 69
Study 29442466 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometriosis group (EM)
Number of subjects: 116
Study 29442466 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometriosis stages III–IV
Number of subjects: 116
Study 25664489 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) (n = 13) consisting of four 45‐second bouts with 1‐minute intervening rest periods (frequency: 50 Hz, amplitude: 2 mm)
Number of subjects: 25
Study 25664489 — intervention group
Group type: COMPARATOR
Intervention: Sham electrical stimulation (n = 12)
Number of subjects: 25
Study 25664489 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) and Sham electrical stimulation
Number of subjects: 25
Study 23286423 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour run at 75% VO(2 max)
Number of subjects: 16
Study 23286423 — intervention group
Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 16
Study 21704360 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized problem-solving (PS) intervention
Number of subjects: 333
Study 21704360 — intervention group
Group type: COMPARATOR
Intervention: Standard asthma education (AE)
Number of subjects: 333
Study 21704360 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 333
Study 19321868 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate circumcision (intervention group)
Number of subjects: 5534
Study 19321868 — intervention group
Group type: COMPARATOR
Intervention: Circumcision after 24 months (control group)
Number of subjects: 5534
Study 16306137 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG) electrolyte balanced solution, 29.5 g daily for 7 days
Number of subjects: 30
Study 16306137 — intervention group
Group type: COMPARATOR
Intervention: Placebo, similar to PEG, for 7 days
Number of subjects: 30
Study 16306137 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG therapy
Number of subjects: 30
Study 12769196 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape-brochure group
Number of subjects: 558
Study 12769196 — intervention group
Group type: EXPERIMENTAL
Intervention: Video only group
Number of subjects: 558
Study 12769196 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 558
Study 10786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac emulsion gel applied every 8 hours for 48 hours
Number of subjects: 120
Study 10786346 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac 75 mg p.o. every 12 hours for 48 hours
Number of subjects: 120
Study 10786346 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study 9381637 — intervention group
Group type: EXPERIMENTAL
Intervention: Likopide (10 mg tablets, orally, twice daily for 3 days, followed by a 3-day interval, then 3 days of treatment)
Number of subjects: 70
Study 9381637 — intervention group
Group type: EXPERIMENTAL
Intervention: Likopide
Number of subjects: 70
Study 9381637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 8239057 — intervention group
Group type: EXPERIMENTAL
Intervention: Padma 28 (340 mg, two tablets bid)
Number of subjects: 36
Study 8239057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 3919831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 120 mg intravenously
Number of subjects: 86
Study 3919831 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide 2 g intravenously
Number of subjects: 86
Study 31814607 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade endoscopic vein harvesting (EVH) from the lower leg
Number of subjects: 0
Study 31814607 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg positioning and synergizing EVH with bridging vein harvesting
Number of subjects: 0
Study 31814607 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade EVH from the lower leg
Number of subjects: 0
Study 30357264 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=101) received a 5-day course involving nursing theory recap and situational role-play using simulated scenarios.
Number of subjects: 198
Study 30357264 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=97) did not receive the intervention.
Number of subjects: 198
Study 30357264 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=101)
Number of subjects: 198
Study 30357264 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=97)
Number of subjects: 198
Study 27852286 — intervention group
Group type: EXPERIMENTAL
Intervention: Best medical treatment plus extracranial-intracranial (EC-IC) bypass surgery
Number of subjects: 330
Study 27852286 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment alone
Number of subjects: 330
Study 25130149 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hCG (200 IU daily)
Number of subjects: 137
Study 25130149 — intervention group
Group type: COMPARATOR
Intervention: Non-hCG group
Number of subjects: 137
Study 22090467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary pattern (DP) including soy protein, nopal, chia seed, and oat, consumed for 2 months with a reduced energy diet (500 kcal reduction).
Number of subjects: 67
Study 22090467 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) beverage, consumed for 2 months with a reduced energy diet (500 kcal reduction).
Number of subjects: 67
Study 20090953 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio Computer Assisted Self Interview (ACASI)
Number of subjects: 758
Study 20090953 — intervention group
Group type: COMPARATOR
Intervention: Self-Administered Questionnaire (SAQ)
Number of subjects: 758
Study 17392718 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort (SJW) 900 mg daily for 12 days
Number of subjects: 9
Study 15629592 — intervention group
Group type: EXPERIMENTAL
Intervention: High-source strength implants (0.76 microGy/m(2)/h)
Number of subjects: 40
Study 15629592 — intervention group
Group type: COMPARATOR
Intervention: Low-source strength implants (0.4 microGy/m(2)/h)
Number of subjects: 40
Study 15629592 — intervention group
Group type: EXPERIMENTAL
Intervention: High-source strength implants
Number of subjects: 40
Study 15629592 — intervention group
Group type: COMPARATOR
Intervention: Low-source strength implants
Number of subjects: 40
Study 12154266 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic stiffness index beta in stroke patients (9.7+/‐5.0)
Number of subjects: 82
Study 12154266 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic stiffness index beta
Number of subjects: 82
Study 10469077 — intervention group
Group type: COMPARATOR
Intervention: 20% hypertonic saline (HS)
Number of subjects: 81
Study 10469077 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% polidocanol (POL)
Number of subjects: 81